Role of Wnt Signaling in Bone Remodeling and Repair

The Wnt genes encode a highly conserved class of signaling factors required for the development of several types of tissues including musculoskeletal and neural structures. There is increasing evidence that Wnt signaling is critical for bone mass accrual, bone remodeling, and fracture repair. Wnt proteins bind to cell-surface receptors and activate signaling pathways which control nuclear gene expression; this Wnt-regulated gene expression controls cell growth and differentiation. Many of the components of the Wnt pathway have recently been characterized, and specific loss-of-function or gain-of-function mutations in this pathway in mice and in humans have resulted in disorders of deficient or excess bone formation, respectively. Pharmacologically targeting components of the Wnt signaling pathway will allow for the manipulation of bone formation and remodeling and will have several orthopedic applications including enhancing bone formation in nonunion and osteoporosis and restricting pathologic bone formation in osteogenic tumors and heterotopic ossification.

[1]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[2]  G. Roodman Regulation of Osteoclast Differentiation , 2006, Annals of the New York Academy of Sciences.

[3]  M. Bouxsein,et al.  Essential role of beta-catenin in postnatal bone acquisition. , 2005, The Journal of biological chemistry.

[4]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[5]  L. Hofbauer,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[6]  P. Kostenuik,et al.  Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. , 2006, Bone.

[7]  C. Niehrs,et al.  Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction , 1998, Nature.

[8]  Hans Clevers,et al.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.

[9]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[10]  A. Üren,et al.  Wnt/Frizzled signaling in Ewing sarcoma , 2004, Pediatric blood & cancer.

[11]  Bart O. Williams,et al.  Essential Role of β-Catenin in Postnatal Bone Acquisition* , 2005, Journal of Biological Chemistry.

[12]  J. Westendorf,et al.  Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.

[13]  J. Behrens,et al.  The Wnt connection to tumorigenesis. , 2004, The International journal of developmental biology.

[14]  D. Ornitz,et al.  Sequential roles of Hedgehog and Wnt signaling in osteoblast development , 2004, Development.

[15]  Xizhi Guo,et al.  Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.

[16]  R. Baron,et al.  Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  Roel Nusse,et al.  Wnt genes , 1992, Cell.

[18]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Gary S Stein,et al.  The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. , 2004, Molecular endocrinology.

[20]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[21]  F. Luyten,et al.  Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. , 2000, Developmental biology.

[22]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[23]  A. McMahon,et al.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors , 2006, Development.

[24]  M. Montcouquiol,et al.  Noncanonical Wnt signaling and neural polarity. , 2006, Annual review of neuroscience.

[25]  R. Baron,et al.  Wnt signaling: a key regulator of bone mass. , 2006, Current topics in developmental biology.

[26]  A. Huvos,et al.  Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma , 2004, International journal of cancer.

[27]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[28]  Walter Birchmeier,et al.  Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. , 2005, Developmental cell.

[29]  R. Nusse,et al.  Wnt signaling in disease and in development , 2005, Cell Research.

[30]  D. Prockop,et al.  How Wnt Signaling Affects Bone Repair by Mesenchymal Stem Cells from the Bone Marrow , 2005, Annals of the New York Academy of Sciences.

[31]  Inke S Näthke,et al.  The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. , 2004, Annual review of cell and developmental biology.

[32]  Chengfeng Zhao,et al.  Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. , 2004, American journal of human genetics.